Mirati Therapeutics, Inc.

Mirati Therapeutics, Inc.

Mirati Therapeutics, Inc.

Overview
Date Founded

2013

Headquarters

9393 Towne Centre Drive,Suite 200,San Diego, CA 92121

Type of Company

Public

Employees (Worldwide)

111

Industries

Pharmaceuticals
Medical Products & Equipment
Medical Support Services
Biotechnology

Company Description

Mirati Therapeutics, Inc. is a clinical-stage oncology company. The firm engages in developing a pipeline of oncology products to treat genetic, immunological and epigenetic drivers of cancer in subsets of cancer patients. Its clinical pipeline consists of glesatinib, sitravatinib and mocetinostat. The company was founded on December 13, 1995 and is headquartered in San Diego, CA.

Contact Data
Trying to get in touch with decision makers at Mirati Therapeutics, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

President & Chief Executive Officer

Executive Vice President, Chief Operating & Financial Officer

Vice President, General Counsel & Corporate Secretary

Executive Vice President & Chief Commercial Officer

Executive Vice President & Chief Scientific Officer

Senior Vice President & Chief Accounting Officer

Executive Vice President & Chief Medical Officer

Senior Vice President, Drug Discovery

Vice President & Head of Human Resources

Senior Vice President, CMC & Product Development

Board of Directors

Co-Founder at Gossamer Bio, Inc.

Chief Medical Officer & Executive Vice President at BioMarin Pharmaceutical, Inc.

Venture Partner at Pappas Capital LLC

Former Vice President, Finance, Chief Financial Officer & Secretary at Horizon Pharmaceutical LLC

Former Executive Chairman at Infectious Disease Research Institute

Chairman & Chief Executive Officer at BCTG Acquisition Corp.

Advisor at Stanford University

President, US Pharmaceuticals at GlaxoSmithKline Pharmaceuticals Ltd.

Paths to Mirati Therapeutics, Inc.
Potential Connections via
Relationship Science
You
Mirati Therapeutics, Inc.
Owners & Shareholders
Details Hidden

AVCAP aims to achieve attractive returns with moderate risk. The firm invests primarily in the equity, debt and associated derivatives of companies operating in the life sciences sector and related industries with a focus on publicly traded, and late-stage private biotechnology companies.

Details Hidden

Founded in 1999, Perceptive Advisors focuses on supporting progress in the life sciences industry by identifying opportunities and directing financial resources toward the most promising technologies in modern healthcare. Today, the firm manages approximately $7.3 billion across our strategies.

Details Hidden

Tavistock Life Sciences invests in a portfolio of public companies and private equity crossover opportunities. Investments tend to focus on focus on biotechnology drug development companies across multiple therapeutic indications.

Recent Transactions
Details Hidden

Mirati Therapeutics, Inc. issued USD Common Stock

Details Hidden

Mirati Therapeutics, Inc. issued USD Common Stock

Details Hidden

Mirati Therapeutics, Inc. issued USD Common Stock

Insider Transactions
Transaction Advisors
Escrow Agent

Advised onMirati Therapeutics, Inc. issued USD Common Stock

Legal Advisor

Advised onMirati Therapeutics, Inc. issued USD Common Stock

Legal Advisor

Advised onMirati Therapeutics, Inc. issued USD Common Stock

Legal Advisor

Advised onMirati Therapeutics, Inc. issued USD Common Stock

Managing Director, ECM

Advised onMirati Therapeutics, Inc. issued USD Common Stock

Legal Advisor

Advised onMirati Therapeutics, Inc. issued USD Common Stock

Advisors & Consultants
Legal Advisor

Partner, San Diego at Cooley LLP

Legal Advisor

Partner at Cooley LLP

Legal Advisor

Partner at Davies Ward Phillips & Vineberg LLP

Clients

BeiGene Ltd. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of innovative molecularly targeted and immuno-oncology drugs for the treatment of cancer. It focuses on Zanubrutinib (BGB-3111), Tislelizumab (BGB-A317), and Pamiparib (BGB-290). The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in Beijing, China.

Key Stats and Financials As of 2019
Market Capitalization
$10.9B
Total Enterprise Value
$4.41B
Earnings Per Share
$-5.69
Debt TEV
0x
TEVNet Income
-20.7x
Enterprise Value / Sales
1,323.45x
Total Equity
$382M
Total Debt
$700K
EBITDAMargin
-6,652.32%
EBITDA
$-222M
Net Profit
$-213M
Revenue
$3.34M
Investors
Details Hidden

The Solidarity Fund QFL is a development capital fund that calls upon the solidarity and savings of Quebec citizens to help create and maintain jobs in Quebec by investing in small and medium-sized businesses

Details Hidden

ProQuest Management invests in healthcare companies located in the US. The sectors in which they invest include biotech and pharmaceutical companies. The firm provides financing for seed to late-stage capital requirements and the firm invests in both public & private companies.

Details Hidden

Chief Executive Officer at Prognomix, Inc.

Suppliers
Array BioPharma Inc. Hospitals & Patient Services | Boulder, CO

Array BioPharma, Inc. is a biopharmaceutical company. Its focus is on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and other high-burden diseases. The company's products are BRAFTOVI and MEKTOVI. Its portfolio includes Binimetinib, Selumetinib, Encorafenib, Filanesib, Ipatasertib, Varltinib, Danoprevir, ARRY-797, Larotrectinib, Tucatinib, ARRY-382, Motolimod, Prexasertib, GDC-0575, LOXO-292, LOXO-195, and AK-1830. The company was founded by Kevin Koch, Anthony D. Piscopio, K. C. Nicolaou, and David L. Snitman in 1998 and is headquartered in Boulder, CO.

Competitors
Merck & Co., Inc. Pharmaceuticals - Kenilworth, NJ

Merck & Co., Inc. , d.b.a. Merck Sharp & Dohme, MSD outside the United States and Canada, is an American pharmaceutical company and is one of the largest pharmaceutical companies in the world.

Johnson & Johnson Pharmaceuticals - New Brunswick, New Jersey

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

GlaxoSmithKline Plc Pharmaceuticals - Brentford, Gbr

GlaxoSmithKline Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the following segments: Pharmaceuticals, Vaccines, Consumer Healthcare, and Corporate Executive Team (CET). The Pharmaceuticals segment focuses on developing medicines in respiratory and infectious diseases, oncology, and immuno-inflammation. The Vaccines segment produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza, and bacterial meningitis. The Consumer Healthcare segment develops and markets brands in the oral health, pain relief, respiratory, nutrition and gastro intestinal, and skin health categories. The CET segment refers to the management of business activities. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Mirati Therapeutics, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Mirati Therapeutics, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Mirati Therapeutics, Inc..